Skip to main content

Table 1 Characteristics of study subjects by the study drug on enrolment

From: Efficacy and safety of artemisinin-naphthoquine versus dihydroartemisinin-piperaquine in adult patients with uncomplicated malaria: a multi-centre study in Indonesia

Characteristic

Artemisinin- naphthoquine(AN)

Dihydroartemisinin- piperaquine(DHP)

P

Overall

Number of subjects

201

200

 

401

Age:mean ± SD (range) years

27.6 ± 10.8 (15–69)

26.2 ± 9.2 (15–67)

0.18

26.9 ± 10.0 (15–69)

Body weight: mean ± SD (range) kgs

58.7 ± 8.5 (36–81)

58.5 ± 8.5 (37–85)

0.86

58.6 ± 8.5 (36–85)

Axillary temperature: mean ± SD (range) °C

37.9 ± 1.0 (36–40.3)

37.9 ± 1.1 (35–40.2)

0.84

37.9 ± 1.1 (35–40.3)

Blood Pressure Systole: mean ± SD (range) mmHg

113 ± 13 (90–150)

114 ± 13 (80–170)

0.44

113 ± 13 (80–170)

Diastole: mean ± SD (range) mmHg

72 ± 9 (50–92)

73 ± 9 (40–120)

0.39

72 ± 9 (40–120)

Heart rate: mean ± SD (range) per min

86 ± 13 (52–126)

87 ± 13 (56–126)

0.59

86 ± 13 (52–126)

Respiration rate: mean ± SD (range) per min

20 ± 3 (16–36)

20 ± 3 (16–32)

0.51

20 ± 3.0 (16–36)

Sex: male:female (%)

181:20 (90:10)

170:30 (85:15)

0.17

351:50 (87.5:12.5)

History of fever in the last 24 hours (%)

195 (97.0)

199 (99.5)

0.12

394 (98.3)

Study subject with T.axillary ≥37.5°C (%)

114 (56.7)

109 (54.5)

0.73

223 (55.6)

History of experience malaria in the last year (%)

160 (79.6)

159 (79.5)

1.00

319 (79.6)

Frequency of malaria in the last year: mean ± SD (range) times

2.6 ± 2.3 (1–20)

2.4 ± 1.6 (1–12)

0.53

2.7 ± 3 (1–20)

History of taken antimalarial drugs in the last 4 weeks (%)

55 (27.4)

57 (28.5)

0.89

112 (27.9)